FDA
-
-
-
-
-
-
-
Lee’s Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China for the Treatment of Recurrent or Metastat
-
-
-
-
-
322,348 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

